Clinical Trial

Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes

Study acronym: COMPASS
Recruiting
View on ClinicalTrials.gov →
Summary
This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).
Trial Details
NCT Number NCT07054125
Lead Sponsor Whole Endo
Collaborators: DexCom, Inc.
Conditions Type 2 Diabetes Mellitus - Poor Control
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2027-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-08